Rotenolone
CAS No. 509-96-6
Rotenolone ( Rotenolone I; 12alpha-HYDROXYROTENONE )
Catalog No. M28011 CAS No. 509-96-6
Rotenolone is a metabolite of Rotenone which is a natural compound derived from plants of the genera Derris and Lonchocarpus.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 538 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRotenolone
-
NoteResearch use only, not for human use.
-
Brief DescriptionRotenolone is a metabolite of Rotenone which is a natural compound derived from plants of the genera Derris and Lonchocarpus.
-
DescriptionRotenolone is a metabolite of Rotenone which is a natural compound derived from plants of the genera Derris and Lonchocarpus.
-
SynonymsRotenolone I; 12alpha-HYDROXYROTENONE
-
PathwayOthers
-
TargetOther Targets
-
Recptoradenylyl cyclase 1(AC1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number509-96-6
-
Formula Weight410.4
-
Molecular FormulaC23H22O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12COc3cc(OC)c(OC)cc3[C@@]1(O)C(=O)c1ccc3O[C@H](Cc3c1O2)C(C)=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Glyoxylic acid monoh...
Glyoxylic acid or oxoacetic acid is an organic compound that is both an aldehyde and a carboxylic acid.It is an intermediate of the glyoxylate cycle which enables certain organisms to convert fatty acids into carbohydrates. The conjugate base of glyoxylic acid is known as glyoxylate.
-
Licoflavonol
Licoflavonol is a novel natural inhibitor of Salmonella T3SS, could be a promising candidate for novel type of anti-virulence drugs, it exhibits a strong inhibitory effect on the secretion of the SPI-1 effector proteins via regulating the transcription of the SicA/InvF genes, and the transportation of the effector protein SipC.
-
Elamipretide 2TFA
Elamipretide is a novel mitochondrion-targeted antioxidant.?Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.